Genomic News and Research

RSS

Atlas of cancer's hidden rules: Unveiling the transcriptomic and epigenetic secrets across 11 tumors

Researchers have mapped the complex epigenetic and transcriptomic landscape of cancer, revealing key regulatory elements across 11 tumor types that could unlock new insights into cancer progression and metastasis.

5 Nov 2023

Science, Innovation, and Xenotransplantation: A Discussion with Dr. Wenning Qin

In this interview, we delve deep into the pioneering world of xenotransplantation and the evolving landscape of gene editing.

2 Nov 2023

PacBio announces HiFi Solves, a global consortium of clinical genomics research leaders

PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the creation of the HiFi Solves consortium.

From PacBio 2 Nov 2023

New study provides insights about mosaic chromosomal alterations in diverse populations

As people age, the DNA in their cells begins to accumulate genetic mutations. Mosaic chromosomal alterations (mCAs), a category of mutations acquired in blood cells, are linked with a 10-fold increased risk of developing blood cancer.

1 Nov 2023

New drug shows promise in killing cancer cells with genetic vulnerability

Imagine the body's cells are well-behaved students in the classroom. The "teachers" are tumor suppressor genes, and they make sure cells follow the rules. But when tumor suppressor genes are away, cells may go astray.

1 Nov 2023

PacBio enables rare and inherited disease research by adding tertiary analysis partners to PacBio Compatible

Partnerships maximize value of HiFi data and complete the full end-to-end workflow for PacBio customers.

From PacBio 1 Nov 2023

Speeding up Alzheimer's research: Progerin turbocharges cellular models for quicker drug screening

The study reveals that introducing progerin, a protein associated with accelerated aging, into cellular models of Alzheimer's Disease (AD) can hasten the development of AD-related traits. This innovative approach offers a more efficient method for studying AD mechanisms, potentially accelerating the discovery of new treatments.

31 Oct 2023

Unsupervised genome-wide variant effect predictor based on pretraining of DNA language models

The Genomic Pre-trained Network (GPN), a multispecies model developed to learn genome-wide variant effects.

31 Oct 2023

Human-to-lion COVID transmission confirmed: Singapore study rings alarm bells for endangered species

The study reveals that the SARS-CoV-2 delta variant was transmitted from humans to lions at a Singapore zoo, emphasizing the risk to captive and endangered animals. The researchers call for strict infection control measures and suggest vaccinations for susceptible animals to protect them from anthropogenic viral transmissions.

30 Oct 2023

Philanthropic funding boost for UK Biobank

Former CEO and Chairman of Google Eric Schmidt, and Ken Griffin, founder and CEO of Citadel and founder of Griffin Catalyst, are today (Monday 30 October) being announced as the first members of a new consortium that will shape the future of the best-in-class UK Biobank, starting with £16 million funding matched by government.

30 Oct 2023

New blood test revolutionizes early cancer detection in Li-Fraumeni Syndrome patients

Canadian researchers develop a cell-free DNA-based multimodal assay for early cancer detection in patients with Li-Fraumeni Syndrome, a high-cancer-risk condition. The assay outperforms conventional methods, promising more sensitive and less invasive cancer surveillance.

29 Oct 2023

Novel replacement strategy holds promise for the treatment of various genetic disorders

Severe Combined Immunodeficiencies (SCIDs) are a group of debilitating primary immunodeficiency disorders, primarily caused by genetic mutations that disrupt T-cell development. SCID can also affect B-cell and natural killer cell function and counts.

27 Oct 2023

Meet Opentrons at ASHG 2023

Opentrons is a proud exhibitor at ASHG 2023, and we’re excited to be bringing our automation solutions to the conference.

From Opentrons 27 Oct 2023

Is retroelement-based gene editing a safer alternative to CRISPR-Cas approaches?

In a Perspective, Stephen Tang and Samuel Sternberg discuss retroelement-based gene editing as a safer alternative to CRISPR-Cas approaches.

26 Oct 2023

Somatic mutations in the skin not responsible for the start or spread of psoriasis

Psoriasis - a chronic skin condition - is not caused or spread by spontaneous genetic mutations in the skin, new research suggests.

26 Oct 2023

Genomic screening encourages people with hemochromatosis to seek treatment and relevant management

Genomic screening to identify hemochromatosis - a disorder that causes iron levels in the body to rise to dangerous levels - encourages people with the condition to seek treatment and ongoing management, a Geisinger study found.

26 Oct 2023

New software tool provides a way for safer design of genome editing

A team of researchers has developed a software tool called DANGER (Deleterious and ANticipatable Guides Evaluated by RNA-sequencing) analysis that provides a way for the safer design of genome editing in all organisms with a transcriptome.

24 Oct 2023

Could the microbiome hold the key to diagnosing and treating biliary tract cancer?

A recent study in "Microorganisms" delves into the relationship between the microbiome and biliary tract cancer, revealing distinct microbial compositions in patients compared to healthy individuals. This research highlights potential diagnostic biomarkers and suggests that altering gut microbial composition might enhance responses to cancer immunotherapy.

24 Oct 2023

Blood test detects cancer earlier in individuals with Li-Fraumeni syndrome

Researchers from The Hospital for Sick Children (SickKids), the Ontario Institute for Cancer Research (OICR) and University Health Network (UHN) have demonstrated that by analyzing patients' blood samples, they are able to detect cancer earlier in individuals with Li-Fraumeni syndrome, an inherited condition with an almost 100 percent life-time risk of developing cancer.

24 Oct 2023

New research aims to understand the ecology of SARS-CoV-2 at the human-animal interface

At the height of the COVID-19 pandemic, Virginia Tech disease ecologists wondered if the virus was having the same effect on wildlife.

24 Oct 2023

Genomic News and Research

Atlas of cancer's hidden rules: Unveiling the transcriptomic and epigenetic secrets across 11 tumors

Science, Innovation, and Xenotransplantation: A Discussion with Dr. Wenning Qin

PacBio announces HiFi Solves, a global consortium of clinical genomics research leaders

New study provides insights about mosaic chromosomal alterations in diverse populations

New drug shows promise in killing cancer cells with genetic vulnerability

PacBio enables rare and inherited disease research by adding tertiary analysis partners to PacBio Compatible

Speeding up Alzheimer's research: Progerin turbocharges cellular models for quicker drug screening

Unsupervised genome-wide variant effect predictor based on pretraining of DNA language models

Human-to-lion COVID transmission confirmed: Singapore study rings alarm bells for endangered species

Philanthropic funding boost for UK Biobank

New blood test revolutionizes early cancer detection in Li-Fraumeni Syndrome patients

Novel replacement strategy holds promise for the treatment of various genetic disorders

Meet Opentrons at ASHG 2023

Is retroelement-based gene editing a safer alternative to CRISPR-Cas approaches?

Somatic mutations in the skin not responsible for the start or spread of psoriasis

Genomic screening encourages people with hemochromatosis to seek treatment and relevant management

New software tool provides a way for safer design of genome editing

Could the microbiome hold the key to diagnosing and treating biliary tract cancer?

Blood test detects cancer earlier in individuals with Li-Fraumeni syndrome

New research aims to understand the ecology of SARS-CoV-2 at the human-animal interface

Industry focus eBook: Genomics (4th edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News